Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hempvana is a U.S. consumer health and wellness company/brand focused on over-the-counter pain-relief topicals and adjacent wellness products. Its portfolio includes maximum-strength trolamine salicylate creams, lidocaine-containing topical pain products, arthritis and nerve pain creams, and supportive accessories such as braces and wearables. The brand markets hemp seed oil-enriched formulations and positions itself as combining natural ingredients with FDA-listed active ingredients for everyday pain management. Hempvana appears to operate primarily as a direct-to-consumer commercial brand rather than a drug-development biotech, with products sold through its own website and mass-market retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hempvana.